MedPath

Study of Bladder-sphincter Symptoms in Functional Neurological Disorders

Recruiting
Conditions
Urinary Bladder Sphincter Disorder
Registration Number
NCT05689866
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

A significant proportion of patients with functional neurological disorders (FND) report urinary, anorectal or genitosexual disorders. However, until now, no study has focused on bladder-sphincter disorders in patients with FND. The symptoms of this pathology are, therefore, not precisely characterized.

Thus, the objective of this research is to specify if urinary, anorectal or sexual disorders can be observed in patients suffering from functional neurological disorders and to better describe them in order to propose better therapeutic options.

Detailed Description

In this clinical study the investigators want to prospectively include all patients presenting to a neurology consultation or day hospital for management of a motor or sensory FND.The patients will first be evaluated for their sphincter functions by self questionnaires. For those where a vesico-sphincter complaint is demonstrated, a neuro-urological consultation will be proposed. A follow-up will then be done, if necessary, in neurology and neuro-urology.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Patient over 18 years of age
  • Diagnosis of Functional Neurological Disorders according to DSM 5 criteria
  • No neurological comorbidity that could account for the sphincter disorders
  • Normal cerebral and spinal cord magnetic resonance imaging.
  • Patient affiliated to a French social security system
  • Patient informed and not objecting to participate in the study

Non inclusion Criteria :

  • Presence of neurological comorbidity that can account for sphincter disorders (e.g. multiple sclerosis, chronic neuropathy, etc.)
  • Pregnancy in progress
  • Candidate for surgery or locoregional treatment
  • Patient subject to legal protection measures.
  • Patient under state medical assistance
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
presence of at least one bladder-sphincter disorderinclusion

This primary endpoint will be measured by the score of the questionnairies which will define the presence of a vesicosphincter disorder (USP), anorectal disorder (Kess and Wexner) or sexual genital disorder (FSFI/IIEF5)

Secondary Outcome Measures
NameTimeMethod
evaluate the nature of bladder and bowel disorders in patients with NFTinclusion

the score of the different questionnairies vesicosphincter disorder (USP), anorectal disorder (Kess and Wexner) or sexual genital disorder (FSFI/IIEF5) that will define the presence of a bladder symptoms

Assess the persistence of bladder and sphincter complaints in patients with NFTs24months

the score of the questionnairies vesicosphincter disorder (USP), anorectal disorder (Kess and Wexner) or sexual genital disorder (FSFI/IIEF5) that will define the presence of a bladder symptoms

Evaluate whether patients with significant vesico-sphincter complaints differ from patients without complaints, including demographic, traumatic, and NFT semiology.24months

comparison of the characteristics of patients on the vesico-sphincter level

To assess whether the clinical and paraclinical patterns of bladder and sphincter disorders differ according to the type of NFT.24months

Analysis of urodynamic assessment data

Trial Locations

Locations (1)

Hospital Avicenne-Neurology

🇫🇷

Bobigny, France

© Copyright 2025. All Rights Reserved by MedPath